Repurposing existing drugs: identification of SARS-CoV-2 3C-like protease inhibitors

Repurposing existing drugs: identification of SARS-CoV-2 3C-like protease inhibitors

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for coronavirus disease 2019 (COVID-19). Since its emergence, the COVID-19 pandemic has not only distressed medical services but also caused economic upheavals, marking urgent the need for effective therapeutics. The experie...

Full description

Bibliographic Details
Main Authors: Wei-Chung Chiou, Meng-Shiuan Hsu, Yun-Ti Chen, Jinn-Moon Yang, Yeou-Guang Tsay, Hsiu-Chen Huang, Cheng Huang
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:
sars-cov-2 3cl protease
antiviral
repurposing drugs
fret
3clpro inhibitors
Online Access:http://dx.doi.org/10.1080/14756366.2020.1850710

Internet

http://dx.doi.org/10.1080/14756366.2020.1850710

Similar Items